TITLE

Suicide fears over weight-loss drug

PUB. DATE
July 2008
SOURCE
PRWeek (London);7/4/2008, p6
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article looks at the suicide concerns over the weight-loss drug Acomplia, manufactured by Sanofi-Aventis. The drug has been approved by the British National Institute for Health and Clinical Excellence (NICE) and it is licensed in the Great Britain for the treatment of obese and overweight patients. However, it is found that rimonabant, the drug's compound name, was banned in the U.S. over fears that it can heighten the risk of suicide. Manning Selvage & Lee is the agency that handles public relations (PR) for the drug.
ACCESSION #
33230310

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics